Noble Capital Markets announced today that it will donate $500 to the Official Hurricane Dorian Relief Effort for every company that registers for its sixteenth annual NobleCon small & microcap investor conference from today through October 31, 2019. Furthermore, additional donations of $100 will be made for each investor registration.

Noble Financial Group, Inc. (“Noble”) announces today that it has launched a new podcast series on its investor portal, Channelchek.com. The series, entitled “IPO” (which stands for “Ideas,” “People behind them” and “Opportunities they create”), is hosted by award-winning director and producer Brant Pinvidic.

QuoteMedia, Inc. (QMCI), a leading provider of market data and financial applications, is pleased to announce that Noble Capital Markets, Inc. has initiated coverage of QuoteMedia – assigning an initial rating of Outperform with a Target Price of $0.25/share.

A Leader in the High Performance Computing Space

Building a Future on Copper.

Successful Energy Marketer Is Set To Expand

Our SAB is a strategic resource whose experience, relationships, and knowledge are utilized throughout NOBLE Life Science Partners to enhance all service offerings. Through the SAB, we have access to world-class healthcare professionals for substantive advice regarding new discoveries, technologies, products, services, and developments.

ProMIS Neurosciences Inc. (TSX:PMN; OTCQB:ARFXF) is pleased to announce that it closed yesterday a private placement of 19,306,668 Units at the price of CDN$0.375 per Unit for gross proceeds of approximately CDN$ 7,240,000.

OSG chief executive Sam Norton tells Noble Capital conference that gains over last five months appear to be holding up. The first signs of a recovery may be showing for tanker rates in the recently slumping US Jones Act market.

Gray Television, Inc. (NYSE: GTN and GTN.A) announced today that it has completed its previously announced and priced underwritten public offering of shares of its common stock at a price to the public of $14.50 per share.

VBI Vaccines Inc. (Nasdaq: VBIV) (TSX: VBV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that the underwriters of its previously announced underwritten public offering have exercised their option to purchase an additional 2,100,000 shares.

NOBLE Life Science Partners (NOBLE LSP), a division of Noble Capital Markets Inc. welcomes Camillo Ricordi, M.D. to its Scientific Advisory Board (SAB)